{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:18:08Z","timestamp":1780589888283,"version":"3.54.1"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:p>\n                           <jats:italic toggle=\"yes\">Mycoplasma pneumoniae<\/jats:italic> is a common cause of community-acquired pneumonia and may cause life-threatening disease in children. We identified 30 (0.3%) confirmed <jats:italic toggle=\"yes\">M. pneumoniae<\/jats:italic> cases by clinical and laboratory criteria in 11,526 pediatric intensive care unit admissions. Outcomes were comparable to patients admitted with other infections (n=3005; <jats:italic toggle=\"yes\">P<\/jats:italic> &gt; 0.1). Our findings indicate that empiric antimicrobial coverage for <jats:italic toggle=\"yes\">M. pneumoniae<\/jats:italic> infection in pediatric intensive care unit is rarely needed.<\/jats:p>","DOI":"10.1097\/inf.0000000000002029","type":"journal-article","created":{"date-parts":[[2018,6,17]],"date-time":"2018-06-17T10:45:51Z","timestamp":1529232351000},"page":"e336-e338","source":"Crossref","is-referenced-by-count":30,"title":["Severe Mycoplasma Pneumoniae Infection in Children Admitted to Pediatric Intensive Care"],"prefix":"10.1097","volume":"37","author":[{"given":"Katie M.","family":"Moynihan","sequence":"first","affiliation":[{"name":"Department of Cardiology, Boston Children\u2019s Hospital, Boston, Massachusetts"},{"name":"Pediatric Intensive Care Unit, Lady Cilento Children\u2019s Hospital, Brisbane, Australia"},{"name":"Pediatric Critical Care Research Group, Mater Research, University of Queensland, Brisbane, Australia"},{"name":"Faculty of Medicine, The University of Queensland, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Barlow","sequence":"additional","affiliation":[{"name":"Pediatric Intensive Care Unit, Lady Cilento Children\u2019s Hospital, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Nourse","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, The University of Queensland, Brisbane, Australia"},{"name":"Infection Management and Prevention Service, Lady Cilento Children\u2019s Hospital, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Heney","sequence":"additional","affiliation":[{"name":"Pathology Queensland, Department of Microbiology, Herston, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanmari\u00e9","family":"Schlebusch","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, The University of Queensland, Brisbane, Australia"},{"name":"Mater Pathology, Mater Misericordiae Ltd, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luregn J.","family":"Schlapbach","sequence":"additional","affiliation":[{"name":"Pediatric Intensive Care Unit, Lady Cilento Children\u2019s Hospital, Brisbane, Australia"},{"name":"Pediatric Critical Care Research Group, Mater Research, University of Queensland, Brisbane, Australia"},{"name":"Faculty of Medicine, The University of Queensland, Brisbane, Australia"},{"name":"Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1574-6976.2008.00129.x","article-title":"Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections.","volume":"32","author":"Atkinson","year":"2008","journal-title":"FEMS Microbiol Rev"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/crj.12149","article-title":"Typical or atypical pneumonia and severe acute respiratory symptoms in PICU.","volume":"9","author":"Hon","year":"2015","journal-title":"Clin Respir J"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children.","volume":"372","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/PCC.0000000000001083","article-title":"Impact of viral respiratory pathogens on outcomes after pediatric cardiac surgery.","volume":"18","author":"Moynihan","year":"2017","journal-title":"Pediatr Crit Care Med"},{"key":"R6-20230912","first-page":"270","article-title":"PCR versus serology for diagnosing Mycoplasma pneumoniae infection: a systematic review & meta-analysis.","volume":"134","author":"Zhang","year":"2011","journal-title":"Indian J Med Res"},{"key":"R7-20230912","first-page":"CD004875","article-title":"Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.","volume":"1","author":"Gardiner","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1001\/jamapediatrics.2017.3225","article-title":"Effectiveness of \u03b2-lactam monotherapy vs macrolide combination therapy for children hospitalized with pneumonia.","volume":"171","author":"Williams","year":"2017","journal-title":"JAMA Pediatr"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.2013.2290","article-title":"Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.","volume":"309","author":"Serisier","year":"2013","journal-title":"JAMA"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/INF.0b013e318247f3e0","article-title":"Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States.","volume":"31","author":"Yamada","year":"2012","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201812000-00031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T23:08:09Z","timestamp":1694560089000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201812000-00031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002029","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}